On Friday, Shares of Cardinal Health, Inc. (NYSE: CAH) showed the bearish trend with a lower momentum of -0.20% and ended its trading session at $49.94. The company traded total volume of 4.47M shares as contrast to its average volume of 3.28M shares. The company has a market value of $16.82B and about 336.77M shares outstanding. During the 52-week trading session, the minimum price at which share price traded was registered at $48.28 and reached the max level of $78.78.
Cardinal Health, Inc. (CAH) recently stated third-quarter fiscal year 2018 revenue of $33.60B, a boost of 6 percent. The company also stated a decline in GAAP operating earnings of 10 percent to $546.0M and a decrease in GAAP diluted earnings per share (EPS) of 33 percent to $0.81. Non-GAAP operating earnings increased 3 percent to $781.0M, while non-GAAP diluted EPS reduced 9 percent to $1.39.
Third-quarter revenue for the Pharmaceutical segment increased 5 percent to $29.70B because of sales growth from pharmaceutical and specialty distribution customers. This was partially offset by the formerly declared expiration of a large, mail-order customer contract and the divestiture of the company’s China distribution business.
Segment profit reduced 3 percent to $596.0M which reflects a modest, negative impact from the company’s generic program performance.
Third-quarter revenue for the Medical segment increased 15 percent to $3.90B, which was driven mainly by the acquisition of the Patient Recovery business.
Segment profit increased 34 percent to $199.0M, driven by contributions from acquisitions. This was partially offset by performance in Cordis and, to a lesser extent, other Cardinal Health Branded products.
The Company offered net profit margin of 1.30% while its gross profit margin was 5.30%. ROE was recorded as 23.70% while beta factor was 1.03. The stock, as of recent close, has shown the weekly downbeat performance of -0.85% which was maintained at -18.49% in this year.